Institutional Ownership Design Therapeutics, Inc. (DSGN)
This table provides information about the institutional ownership of Design Therapeutics, Inc. (DSGN). We have compiled data on the 101 institutions that hold shares in the stock, with a total of 33.1 Million shares, which have been reported (via 13F filing form) to have a value of $144 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Sr One Capital Management, LP
|
May 13, 2025 Q1 2025 |
6,526,476
shares
|
$21.9 Million
11.4% of portfolio
|
Q4 2022
Added 16.0%
|
|
Logos Global Management LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
4,217,627
shares
|
$14.2 Million
3.17% of portfolio
|
Q3 2024
Reduced 16.19%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,304,948
shares
|
$7.74 Million
0.0% of portfolio
|
Q2 2024
Added 1.35%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
May 15, 2025 Q1 2025 |
1,953,547
shares
|
$6.56 Million
0.47% of portfolio
|
Q4 2024
Added 3.22%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
May 15, 2025 Q1 2025 |
1,817,858
shares
|
$6.11 Million
0.02% of portfolio
|
Q1 2025
Reduced 2.09%
|
|
Baker Bros. Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
1,743,725
shares
|
$5.86 Million
0.08% of portfolio
|
Q3 2024
Added 2.86%
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
1,680,975
shares
|
$5.65 Million
0.42% of portfolio
|
Q1 2025
Added 13.5%
|
|
Almitas Capital LLC
Santa Monica, CA |
May 15, 2025 Q1 2025 |
1,452,896
shares
|
$4.88 Million
3.17% of portfolio
|
Q1 2025
Added 9.76%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
1,427,467
shares
|
$4.8 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.23%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
963,460
shares
|
$3.24 Million
0.0% of portfolio
|
Q1 2025
Added 0.49%
|
|
Driehaus Capital Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
913,399
shares
|
$3.07 Million
0.04% of portfolio
|
Q1 2025
Added 17.69%
|
|
Kynam Capital Management, LP
Princeton, NJ |
May 15, 2025 Q1 2025 |
904,017
shares
|
$3.04 Million
0.29% of portfolio
|
Q1 2025
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
775,497
shares
|
$2.61 Million
0.0% of portfolio
|
Q1 2025
Added 1.82%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
714,074
shares
|
$2.4 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.28%
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
645,694
shares
|
$2.17 Million
0.02% of portfolio
|
Q1 2025
New holding
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
567,604
shares
|
$1.91 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.67%
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
562,943
shares
|
$1.89 Million
0.4% of portfolio
|
Q1 2025
Added 0.61%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
395,251
shares
|
$1.33 Million
0.0% of portfolio
|
Q1 2025
Reduced 22.85%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
373,653
shares
|
$1.26 Million
0.0% of portfolio
|
Q1 2025
Reduced 3.73%
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
288,602
shares
|
$969,702
0.0% of portfolio
|
Q1 2025
Added 34.07%
|
|
Goldman Sachs Group Inc
New York, NY |
May 09, 2025 Q1 2025 |
266,016
shares
|
$893,813
0.0% of portfolio
|
Q1 2025
Reduced 10.47%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
265,000
shares
|
$890,400
0.0% of portfolio
|
Q1 2025
Added 4.54%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
258,375
shares
|
$868,140
0.0% of portfolio
|
Q1 2025
Reduced 2.38%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
247,878
shares
|
$832,870
0.0% of portfolio
|
Q1 2025
Reduced 28.4%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
158,004
shares
|
$530,893
0.0% of portfolio
|
Q4 2024
Reduced 25.66%
|